Disease Info Card

Pulmonary Embolism

Information about Pulmonary Embolism: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Pulmonary Embolism

Most recent studies have shown that Pulmonary Embolism shares some biological mechanisms with deep-vein-thrombosis, dyspnea, embolism, heart-failure, hemorrhage, hypertensive-disease, infarction, lung-diseases, malignant-neoplasms, myocardial-infarction, neoplasms, pain, pulmonary-hypertension, pulmonary-thromboembolism, thromboembolism, thrombophlebitis, thrombosis, thrombus, venous-thromboembolism, venous-thrombosis.

Among the many pathways, these few ones have gauged particular interests from scientists studying Pulmonary Embolism, and have been seen in publications frequently: Aging, Angiogenesis, Blood Circulation, Blood Coagulation, Coagulation, Dehiscence, Fibrinolysis, Flight, Hemostasis, Hypersensitivity, Localization, Pathogenesis, Platelet Activation, Platelet Aggregation, Reflex, Secretion, Transport, Vasoconstriction, Vasodilation, Wound Healing

Quite a number of genes have been found to play important roles in Pulmonary Embolism, such as ALB, AMY2A, AP3B1, BLOC1S6, EPB42, EPHA2, F10, F2, F5, PCYT1A, PLAT, PLAU, PLG, PREP, PRH1, SERPINC1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.